Low reactogenicity of the virosomal subunit influenza vaccine in healthy children without risk factors

Vacunas

Volumn 10, Issue 4, 2009, Pages 113-117

  Salleras, L ^a,b   Dominguez A ^a,b   Pumarola, T ^b   Prat, A ^a,b   Marcos, M A ^b   Garrido, P ^a   Artigas, R ^b   Bau, A ^b   Brotons, J ^c   Bruna, X ^c   Catala P ^c   Carreras, E ^c   Cuadra, D ^c   Gatell, A ^c   Millet, S ^c   Oller, J ^c   Raga, E ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Paediatric Primary Health Care Research Group   (Spain)

Author keywords

Children; Reactogenicity; Virosomal influenza vaccine

Indexed keywords

INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIROSOMAL INFLUENZA VACCINE;

ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; COMMON COLD; DRUG EFFICACY; ERYTHEMA; FATIGUE; FEMALE; FEVER; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INJECTION PAIN; MALAISE; MALE; NORMAL HUMAN; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; SKIN INDURATION; VOMITING;

EID: 77950494835     PISSN: 15769887     EISSN: 15788857     Source Type: Journal    
DOI: 10.1016/S1576-9887(09)73476-4     Document Type: Article

References (44)

1. W.P. Glezen Serious morbidity and mortality associated with influenza epidemics Epidemiol Rev 4 1982 25 44 (Pubitemid 13249672)
2. H.S. Izurieta, W.W. Thompson, P. Kramarz, D.K. Shay, R.L. Davis, and F. DeStefano Influenza and the rates of hospitalization for respiratory disease among infants and young children N Engl J Med 342 2000 232 239 (Pubitemid 30058954)
3. K.M. Neuzil, B.G. Mellen, P.F. Wright, E.F. Mitchel Jr, and M.R. Griffin The effect of influenza on hospitalizations, outpatient visits and courses of antibiotics in children. N Engl J Med 342 2000 225 231
4. W.P. Glezen, L.H. Taber, A.L. Frank, W.C. Gruber, and P.A. Piedra Influenza virus infections in infants Pediatr Infect Dis J 16 1997 1065 1068
5. F.M. Muñoz The impact of influenza in children Semin Pediatr Infect Dis 13 2002 72 78
6. T. Heikkinen, T. Ziegler, V. Peltola, P. Lehtinen, P. Toikka, M. Lintu, et al. Incidence of influenza in Finnish children Pediatr Infect Dis J 22 2003 S204 S206
7. T. Heikkinen, H. Silvennoinen, V. Peltola, T. Ziegler, R. Vainionpaa, and T. Vuorinen Burden of influenza in children in the community J Infect Dis 190 2004 1369 1373 (Pubitemid 39332175)
8. K.M. Neuzil, C. Hohlbein, and Y. Zhu Illness among schoolchildren during influenza season. Effect on school absenteeism, parental absenteeism from work, and secondary illness in families Arch Pediatr Adolesc Med 156 2002 986 991 (Pubitemid 36343474)
9. G.A. Poland, and C. Breese Hall Influenza immunization of schoolchildren: Can we interrupt community epidemics? Pediatrics 103 1999 1280 1282
10. CDC Prevention and control of influenza Recommendations of Advisory Committee on Immunization Practices (ACIP) MMWR 51 2002 1 34
11. American Academy of Pediatrics Policy Statement Committee on Infectious Diseases. Reduction of the Influenza Burden in Children Pediatrics 110 2002 1246 1252
12. CDC Advisory Committee on Immunization Practices Recommended childhood and adolescent immunization schedule -United States. July-December 2004 MMWR 53 2004 Q1 3
13. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for influenza vaccination in children Pediatrics 113 2004 1441 1447
14. CDC Prevention and control of influenza Recommendations of Advisory Committee on Immunization Practices (ACIP) MMWR 55 2006 1 42
15. Committee on Infectious Diseases American Academy of Pediatrics. Prevention of influenza: Recommendations for Influenza Immunization of children, 2008-2009 Pediatrics 122 2008 1135 1141
16. A.E. Fiore, D.K. Shay, K. Broder, J.K. Iskander, T.M. Uyeki, G. Mootrey, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 57 2008 1 60
17. K.M. Neuzil, L.A. Jackson, J. Nelson, A. Klimov, N. Cox, and C.B. Bridges Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children J Infect Dis 194 2006 1032 1039 (Pubitemid 44547642)
18. K.M. Edwards, and M.R. Griffin Influenza vaccination of children: Can it be accomplished? J Infect Dis 194 2006 1027 1029 (Pubitemid 44547640)
19. K.A. Poehling, K.M. Edwards, G.A. Weinberg, P. Szilagyi, M.A. Staat, M.K. Iwane, et al. for the new Vaccine Surveillance Network The underrecognized burden of influenza in young children N Engl J Med 355 2006 31 40
20. W.P. Glezen Influenza control N Engl J Med 355 2006 79 81
21. Prevention and control of influenza Recommendations of Advisory Committee on Immunization Practices (ACIP) MMWR 53 2004 1 40
22. K.M. Zangwill, and R.B. Belshe Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination Pediatr Infect Dis J 23 2004 189 200
23. T. Jefferson, S. Smith, V. Demicheli, A. Harnden, A. Rivetti, and C. Di Pietrantonj Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review Lancet 365 2005 773 780 (Pubitemid 40311364)
24. E. Negri, C. Colombo, L. Giordano, N. Groth, G. Apolone, and C. La Vecchia Influenza vaccine in healthy children: a meta-analysis Vaccine 23 2005 2851 2861 (Pubitemid 40386486)
25. L. Salleras, A. Dominguez, T. Pumarola, A. Prat, M.A. Marcos, and P. Garrido Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: A prospective cohort study Vaccine 24 2006 6638 6642 (Pubitemid 46107153)
26. L. Salleras, E. Navas, A. Domínguez, D. Ibáñez, A. Prat, P. Garrido, et al. Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3-14 years during the annual health examination in private paediatric offices Vaccine 27 2009 3454 3458
27. E. Navas, L. Salleras, A. Domínguez, D. Ibáñez, A. Prat, and J. Sentís Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives Vaccine 25 2007 3233 3239 (Pubitemid 46505049)
28. C.B. Bridges, J.M. Katz, R.A. Levandowski, and N.J. Cox Inactivated influenza vaccines S.A. Plotkin, W.A. Orenstein, P.A. Offit, editors. Vaccines 5th ed. 2008 Saunders Elsevier Philadelphia 259 290
29. L. Salleras La seguridad de las vacunas Vacunas 4 2003 18 21
30. T. Lasky, G.J. Terracciano, L. Magder, C.L. Koski, M. Ballesteros, and D. Nash The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines N Engl J Med 339 1998 1797 1802 (Pubitemid 29005783)
31. D.N. Juurlink, T.A. Stukel, J. Kwong, A. Kopp, A. McGeer, and R.E. Upshur Guillian-Barré syndrome after influenza vaccination in adults: a population-based study Arch Intern Med 166 2006 2217 2221 (Pubitemid 44748768)
32. P. Haber, F. DeStefano, F.J. Angulo, J. Iskander, S.V. Shadomy, and E. Weintraub Guillain-Barré syndrome following influenza vaccination JAMA 292 2004 2478 2481 (Pubitemid 39552672)
33. P.F. Wright, J.D. Cherry, H.M. Foy, W.P. Glezen, C.B. Hall, K. McIntosh, et al. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children-a multicentered evaluation of dosage and safety Rev Infect Dis 5 1983 758 764
34. D.W. Barry, R.E. Mayner, H.D. Hochstein, R.C. Dunlap, S.C. Rastogi, J.E. Hannah, et al. Comparative trial of influenza vaccines. II. Adverse reactions in children and adults Am J Epidemiol 104 1976 47 59
35. P.F. Wright, J. Thompson, W.K. Vaughn, D.S. Folland, S.H. Sell, and D.T. Karzon Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity J Infect Dis 136 Suppl 1977 S731 S741 (Pubitemid 8286956)
36. C. Herzog, K. Hartmann, V. Künzi, O. Kürsteiner, R. Mischler, H. Lazar, et al. Eleven years of Inflexal V -a virosomal adjuvanted influenza vaccine Vaccine 27 2009 4381 4387
37. G. Kanra, P. Marchisio, C. Feiterna-Sperling, G. Gaedicke, H. Lazar, and P. Durrer Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children Pediatr Infect Dis J 23 2004 300 306 (Pubitemid 38508880)
38. G.V. Zuccotti, A. Zenga, P. Durando, L. Massone, B. Bruzzone, and D. Sala Immunogenicity and tolerability of a trivalent virosomal influenza vaccine in a cohort of HIV-infected children J Int Med Res 32 2004 492 499 (Pubitemid 39255594)
39. G.V. Zuccotti, C. Cucchi, D. Sala, and M. Giovannini Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children Acta Paediatr 91 2002 486 487
40. V. Künzi, M. Dornseiff, J. Horwath, and K. Hartmann Safe vaccination of children with a virosomal adjuvanted influenza vaccine Vaccine 27 2009 1261 1265
41. O. Kürsteiner, C. Moser, H. Lazar, and P. Durrer Inflexal® V -the influenza vaccine with the lowest ovalbumin content Vaccine 24 2006 6632 6635 (Pubitemid 46107152)
42. P. Conne, L. Gauthey, P. Vernet, B. Althaus, J.U. Que, and B. Finkel Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients Vaccine 15 1997 1675 1679 (Pubitemid 27445747)
43. R. Glück, R. Mischler, B. Finkel, J.U. Que, B. Scarpa, and S.J. Cryz Jr Immunogenicity of new virosome influenza vaccine in elderly people Lancet 344 1994 160 163 (Pubitemid 24218879)
44. S. Esposito, C. Gasparini, A. Martelli, A. Zenga, E. Tremolati, E. Varin, et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy Vaccine 26 2008 4664 4668